Ligneous conjunctivitis exacerbated by Pseudomonas aeruginosa - Diagnostic and therapeutic approach

Madiha Tariq1, Muhammad Abdullah Zahid2, Taimoor Ashraf Khan3

  • 1Unit 1, Institute of Ophthalmology, Mayo Hospital, Lahore, Pakistan.

Insights

Ligneous conjunctivitis, a rare eye disease, can be worsened by multidrug-resistant Pseudomonas aeruginosa. A novel triple therapy combined with antibiotics proved effective in a pediatric case.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Genetics

Background:

  • Ligneous conjunctivitis is a rare, chronic inflammatory condition characterized by pseudomembrane formation on ocular mucosal surfaces.
  • Plasminogen deficiency is the primary suspected cause, but infectious agents may exacerbate the disease.
  • Treatment for ligneous conjunctivitis is often challenging and requires a multifaceted approach.

Observation:

  • A 3-year-old female presented with ligneous conjunctivitis.
  • Cultures from the pseudomembranes isolated a multidrug-resistant strain of Pseudomonas aeruginosa.
  • This marks the first reported instance of P. aeruginosa involvement in exacerbating ligneous conjunctivitis.

Findings:

  • A multidrug-resistant Pseudomonas aeruginosa strain was identified as a potential exacerbating factor in a pediatric case of ligneous conjunctivitis.
  • A treatment regimen combining corticosteroids, heparin, and cyclosporine, supplemented with targeted antibiotics, demonstrated efficacy.
  • This case highlights the potential role of bacterial infections in the pathogenesis and exacerbation of ligneous conjunctivitis.

Implications:

  • The findings suggest that infectious agents, specifically multidrug-resistant Pseudomonas aeruginosa, can play a significant role in the exacerbation of ligneous conjunctivitis.
  • The successful use of a triple therapy regimen (corticosteroids, heparin, cyclosporine) plus antibiotics offers a promising therapeutic strategy for complex cases.
  • This case underscores the importance of identifying and treating infectious agents in ligneous conjunctivitis for improved patient outcomes.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
884
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
69
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
745
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
492